Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +0.08% | +0.24% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Colin S. Dunn
CEO | Chief Executive Officer | - | - |
David Smith
DFI | Director of Finance/CFO | 58 | - |
Maria Pia Muniz
COO | Chief Operating Officer | - | 01/03/01 |
Kalust Ucar
CTO | Chief Tech/Sci/R&D Officer | - | 01/14/01 |
Stephen Minger
PRN | Corporate Officer/Principal | - | - |
Bobbie L. King
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Colin S. Dunn
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,657,206 | 12,860,956 ( 94.17 %) | 0 | 94.17 % |
Company contact information
Charles River Laboratories Cell Solutions, Inc.
8500 Balboa Boulevard Suite 130
91325, Northridge
+
http://www.hemacare.com/Sector
1st Jan change | Capi. | |
---|---|---|
+0.24% | 346M | |
+19.22% | 84.52B | |
-27.14% | 72.21B | |
+4.65% | 27.74B | |
-6.23% | 17.97B | |
0.00% | 17.46B | |
+3.30% | 15.82B | |
+7.44% | 13.55B | |
+6.80% | 13.31B | |
+73.32% | 13.32B |
- Stock Market
- Equities
- HEMA Stock
- Company HemaCare Corporation